Automated Inline Inspection Technologies for Complete Quality Control
CCIT provides automated inspection solutions across all PTI technology platforms – Vacuum Decay, Airborne Ultrasound and MicroCurrent HVLD.
Automated Testing to optimize QA/QC
In addition to offline laboratory systems for leak detection and package quality testing, we offer configurations that provide the capability of fully automated inspection. Automated Systems have been designed using PTI’s VeriPac, MicroCurrent HVLD and Airborne Ultrasound technologies for applications that include automated statistical process control (SPC) testing up to fully automated robotic pick and place package handling.
Automated Inspection of Parenterals
Automation and digital measurement systems have systematically become a greater part of pharmaceutical manufacturing. The ability to capture better quality data and provide a seamless data integrity solution is critical to all applications. Nowhere is this more evident than in the parenteral fill-finish environment. Considering the guidance documentation and vision of different regulatory bodies, focusing on CCI within the fill-finish arena becomes an incredibly effective space to develop a solution to assure CCI with the highest level of reliability in an automated fashion. Either of PTI’s parenteral CCI solutions (HVLDMC or Vacuum Decay) can effectively be deployed for the wide range of parenteral package formats and application requirements in a robotic automated platform. Between the two technologies, 95% of parenteral applications can be tested for CCI down to critical to quality leak sizes.
Show moreShow Less
PTI’s robotic automated inspection platform provides best in class CCI testing with no compromise within the parenteral process. PTI’s technologies provide the reliability and accuracy in test measurement, while the automation platform provides the flexibility needed to not compromise on quality.
HVLDMC and Vacuum Decay overlap in capabilities, but more importantly encompass the full parenteral market range. Both technologies are validated as non-destructive methods with leak detection sensitivity down to critical parenteral leak sizes. The technologies are specifically referenced in USP’s Chapter 1207 and have been the subject of depth of scientific research supporting the effectiveness of the measurement solutions. A robust inspection solution to meet the needs of the biologics industry is simply a matter of automating and scaling the functions typically performed by an operator in an offline setting.